Reproductive pharmacoepidemiology includes research in all areas of human reproduction, such as drugs during pregnancy and the neonatal period, drugs for infertility, hormonal contraception and drugs related to the menopause.

Knowledge considering drug use during pregnancy and in childhood is limited. Some medications may not be safe to use during pregnancy and several drugs, which are used to treat children have not been approved for such use. In addition, many diseases are increasing in frequency or occur in connection with menopause. Accordingly, further steps to assess consequences of drug use in relation to human reproduction is needed.

Researchers at CPE are involved in several studies focusing on consequences to the mother and the infant of drugs used during pregnancy and infancy. In particular we have studied drugs used for treatment of depression and other psychiatric diseases and anti-inflammatory treatment. Other important areas in which CPE researchers are involved include venous thromboembolism in connection with hormonal contraception, post-menopausal osteoporosis, and occurrence of psychiatric and cardiovascular diseases in connection with menopausal hormone therapy.

The research area is led by:

Carolyn Cesta


Publications on PubMed

Content reviewer:
Karin Gembert